These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1279829)

  • 21. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM; Olesin AI
    Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina].
    Zaslavskaia RM; Kelimberdieva ES; Komissarova IA; Teĭblium MM; Goncharov LF; Goncharova ZF; Akhmetov KZh
    Ter Arkh; 1999; 71(11):58-61. PubMed ID: 10626340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
    Knight C; Purcell H; Fox K
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():229-36. PubMed ID: 7647027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1981 Oct; 21(10):59-64. PubMed ID: 6170776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the clinical use of a new drug in the therapy of coronary insufficiency].
    Bracchetti D; Spada E
    G Clin Med; 1966 Dec; 47(12):1261-82. PubMed ID: 4173047
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience using ethacizine in myocardial infarct patients].
    Kukes VG; Ponomarenko EL; Starodubtsev AK
    Kardiologiia; 1987 May; 27(5):97-8. PubMed ID: 2443746
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 29. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics].
    Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI
    Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clinico-hemodynamic effects of the activator of the GABA-ergic stress-limiting system sodium valproate (acediprol) and etatsizin in patients with cardiac arrhythmias].
    Skibitskiĭ VV; Meerson FZ; Petrova TR; Meliukhova NE
    Kardiologiia; 1992 Jul; 32(7-8):21-5. PubMed ID: 1283180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical efficacy of diltiazem and the means for enhancing it in treating patients with ischemic heart disease combined with chronic bronchitis].
    Siurin AA; Ionov VA
    Kardiologiia; 1993; 33(3):20-2. PubMed ID: 8377333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiarrhythimic properties of ethmozine].
    Kaverina NV; Senova ZP; Vikxliàev IuI; Ul'iànova OV
    Farmakol Toksikol; 1970; 33(6):693-7. PubMed ID: 4103389
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of ventricular extrasystoles with Cordichin].
    Philipp H
    Med Welt; 1982 Sep; 33(36):1245-7. PubMed ID: 6182441
    [No Abstract]   [Full Text] [Related]  

  • 34. [The anti-ischemic effect of angiotensin-converting enzyme inhibitors in treating stable stenocardia of effort in middle-aged and elderly patients].
    Lazebnik LB; Vertkin AL; Drozdova SL; Konev IuV; Goncharov LF
    Ter Arkh; 1996; 68(4):40-2. PubMed ID: 9324787
    [No Abstract]   [Full Text] [Related]  

  • 35. [Predicting changes in hemodynamics and anti-arrhythmic effectiveness of neogilurytmal].
    Nesvetov VN; Shpektor AV; Gorshkov VA
    Sov Med; 1987; (10):36-9. PubMed ID: 2447655
    [No Abstract]   [Full Text] [Related]  

  • 36. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new Soviet drug, ethacizine, in the treatment of ventricular rhythm disorders].
    Kukes VG; Smetnev AS; Ponomarenko EL; Burian EF; Starodubtsev AK
    Kardiologiia; 1983 Nov; 23(11):45-7. PubMed ID: 6197556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness and characteristics of the action of etmozin in treating extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG; Kaukenas IK
    Ter Arkh; 1986; 58(6):65-70. PubMed ID: 2429380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
    Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
    Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.